1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsERIS Topics is sponsored by DARPA - Biological Technologies Office. Supports technologies for defense of humans and elements of the bioeconomy; technologies for human health and performance optimization.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DARPA - Expedited Research Innovation System (ERIS) - Defence Science Institute DARPA – Expedited Research Innovation System (ERIS) DARPA – Expedited Research Innovation System (ERIS) ERIS is used by DARPA to obtain solutions or capabilities that deliver breakthrough technologies, processes, research, or methods in the interest of United States national security.
ERIS is a tool to present revolutionary technologies, capabilities, and research to DARPA in an environment with a rapid acquisition, Other Transaction-based pathway. ERIS accepts video submissions on selected topics which are assessed on a monthly basis. Developing advanced technologies for improved resilience, efficiency and effectiveness of strategic systems.
This topic area supports technologies for critical infrastructure and military command-and-control systems (networks and applications across strategic, command, operational, and tactical edges). Advanced technologies for defense against potential chemical and biological threats, human-made or naturally occurring.
This topic supports technologies for defense of humans and elements of the bioeconomy critical to national security, including agricultural crops, livestock, and biomanufacturing production organisms that deliver threat surveillance, threat detection, threat diagnosis, countermeasure design, countermeasure deployment, and threat attribution, to include simulation-based and experiment-based technologies.
Advanced technologies for the improved resilience of US operations throughout the prepare, deployment, execute and return cycle. This topic supports technologies for human health and performance optimization. This topic supports biotechnologies for production of supplies, in situ resource utilization, and creation of operational advantages, including in austere locations.
This topic supports technologies in the convergence of Artificial Intelligence and Machine Learning (AI/ML) with chemistry and biology, including foundation models and data factories. Disruptive system concepts, platform design, and infrastructure innovation that advance technologies for space operations in LEO/MEO/GEO and Cislunar space.
This topic supports innovations in a broad range of categories to include but not limited to: space vehicle design; thermal management; next generation thruster design; in-situ resource extraction; fuel generation; microgravity manufacturing and biomanufacturing; autonomous systems to include the convergence of Artificial Intelligence and Machine Learning (AI/ML) for space systems resource optimization delivering operational advantages; and manufacturing at speed and scale.
Master Program Announcement – ERIS – DARPA+ERIS+Announcement-+R10+1+May+2026 You may be also interested in ... US CDMRP – Multiple Sclerosis Research Program Investigator-Initiated Research Award - HT942526MSRPIIRA Letters of Intent due 30 July... DARPA – Biological Technologies Broad Agency Announcement – HR001126S003 DARPA's Biological Technologies Office is seeking abstract proposals that leverage...
US Defense Health Agency – BAA for Extra Mural Medical Research – HT942523SBAA1 The Defense Health Agency is seeking proposals for funding in...
According to the current listing, eligibility includes: Open to all qualified applicants. Confirm the full requirements in the official notice before applying.
ERIS Topics is funded by DARPA - Biological Technologies Office. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read article